Anthem Blue Cross (HMO, PPO, EPO) |
Evkeeza (evinacumab-dgnb) |
Drugs for the Heart : Drugs for Cholesterol |
- Step Therapy Applies
For FAX form click HERE Our electronic prior authorization (ePA) process is the preferred method for submitting pharmacy prior authorization requests. Creating an account is free, easy and helps patients get their medications sooner. You can complete the process through your current electronic health record/electronic medical record (EHR/EMR) system or by using one of these ePA sites: Log in to Surescripts Log in to CoverMyMeds; For details on drug coverage click HERE; Dosing Limit: 15 mg/kg every 4 weeks;
- PA Applies
- Prior Authorization: HoFH:
Documented Diagnosis: Yes
Medical Test Required: Yes
Duration: 6 Month(s)
Reauthorization Required: Yes
- HoFH:
Duration: 6 Month(s)
Required Medical Information: 1 of ApoB level;Baseline Labs Non-HDL-C;Evidence of HeFH in both parents for HoFH;Genetic confirmation of mutation in LDL receptor;History of untreated/pretreated LDL
Documented Diagnosis: Yes
Medical Test Required: Yes
Reauthorization Required: Yes
Duration of Reauthorization: = 1 year(s)
Diagnosis verbiage includes presence of cutaneous or tendon xanthomas before age 10: Yes
Diagnosis verbiage includes evidence of HeFH in both parents: Yes
Baseline LDL-C Level to Initiate Therapy (% reduction): N/A
Baseline LDL-C Level to Initiate Therapy (mgdL): <= 300
Concomitant therapy required with Bile acid sequestrant or niacin: No
Concomitant therapy required with ezetimibe: No
Concomitant therapy required with maximally tolerated statin: No
Documentation Period of LDL-C Levels: N/A
LDL-C Level for Reauthorization (mgdL): Unspecified
LDL-C Level for Reauthorization (% reduction): N/A
Lifestyle modifications required: No
PushTronex MUST be used after Syringe or Sureclick: No
|